Urinary and Kidney

Research and Trials 01 Jan 2013

The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney

Measurement of reactive oxygen species production and antioxidant system status before and directly after reperfusion of the transplanted kidney and influence of oxidant stress on kidney function in 2 and 6 weeks. Official TitleThe Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney.
Research and Trials 01 Jan 2013

Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

Alemtuzumab is a man-made antibody used to treat certain blood disorders. This study will evaluate treatment of kidney transplant recipients with alemtuzumab and other immune system suppressing medications with or without infusions of bone marrow stem cells from the kidney donor. The purpose of this study is to find out…
Research and Trials 01 Jan 2013

Far Infrared Treatment for Kidney Diseases

Renal failure or kidney failure is a situation in which the kidneys fail to function adequately. It is divided into acute and chronic forms; either form may be due to a large number of other medical problems. Official Title Phase 1 Study to Examine the Use of Far Infrared Radiation…
Research and Trials 01 Jan 2013

Kidney Stone Structural Analysis By Helical Computed Tomography (CT)

Current practices of the diagnosis of urinary stones gives little information on the probable fragility of stones using shock wave lithotripsy (SWL), and many patients receive more SW’s than is necessary to break up their stones. Indeed, some patients are treated with SWL when their stones cannot be fragmented using…
Research and Trials 01 Jan 2013

Randomised Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

This study will assess the effects of vitamin D3 supplementation (cholecalciferol; 2000 IU daily) on serum calcium levels, circulating vitamin D levels, and markers of kidney disease and cardiovascular risk among people with diabetes mellitus and early kidney disease. Eligibility criteria include type 2 diabetes and stage 1-2 chronic kidney…
Blood 01 Jan 2013

Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy

Autosomal-Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary renal disease, characterised by the progressive development of fluid-filled cysts in the kidney leading to progressive loss of renal function and eventually to renal failure. It is responsible for 8% to 10% of the cases of end stage renal disease…
Cancer 01 Jan 2013

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer

Rationale: Learning about the long-term effects of dietary, lifestyle, and environmental factors on the risk of cancer progression and recurrence may help the study of bladder cancer in the future.Purpose: This clinical trial is studying how dietary, lifestyle, and environmental factors affect patients with early-stage bladder cancer.  Official TitleBladder Cancer Prognosis Programme (Incorporating SELENIB Trial).
Blood 01 Jan 2013

Intravenous Iron in Patients With Anaemia of Chronic Kidney Disease

The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy. Official Title Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease. Conditions Chronic…
Blood 01 Jan 2013

Iron Sucrose in Stage 3/4 Kidney Disease